CA19-9 test
Date:
October 19, 2026
Category:
CA19-9 test
Detects CA19-9—a marker for pancreatic and gastrointestinal tract cancer. Intended for professional use (in vitro diagnostics).
Contact our sales team for availability and delivery time
What is this test?
The CA19-9 test detects carbohydrate antigen 19-9 in the blood, a marker associated with pancreatic and bile duct tumors. It is used to monitor treatment effectiveness and disease progression, but is not suitable for cancer screening because it can also be elevated due to benign conditions such as pancreatitis or bile stasis.
Technical information
- Method
- Lateral flow chromatographic immunoassay
- Result in
- 10 min
- Storage temperature
- 2–30 °C
- Shelf life
- 24 months
- Sensitivity
- 96.9 %
- Specificity
- 98.7 %
- Accuracy
- 98.3 %
- Equipment
- Not required – visual reading
- Compliance
- CE-marked in vitro diagnostic device
Variants and order codes
| Code | Specimen | Format | Pack size | Cut-off |
|---|---|---|---|---|
| AF-AK6QU4 | Whole blood / serum / plasma | Cassette | 10 tests | 40 U/mL |